EUVIMEDSkopri EUVIMED
Übersichtsarbeit

Exploring promising minor natural phenolic compounds in neuroprotection‐related preclinical models

Carlos Franciney Moreira Vasconcelos iD, Agnieszka Zofia Neugebauer iD, Ricardo Basto Souza iD

Basic & Clinical Pharmacology & Toxicology · 2024

DOI: 10.1111/bcpt.14006 ↗

At a glance

Übersichtsarbeit in Basic & Clinical Pharmacology & Toxicology, 2024. Written by Carlos Franciney Moreira Vasconcelos and 2 co-authors. Institution: University of Medicine of Göttingen (UMG), Göttingen, Germany. Major MEDLINE topics: Neuroprotective Agents, Phenols. Cited 7 times so far (Crossref); 71 references.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, are characterised by the progressive loss of specific neuronal cell populations due to multifactorial factors, including neurochemical and immunological disturbances. Consequently, patients can develop cognitive, motor and behavioural dysfunctions, which lead to impairments in their quality of life. Over the years, studies have reported on the neuroprotective properties inherent in phenolic compounds. Therefore, this review highlights the most recent scientific findings regarding phenolic compounds as promising neuroprotective molecules against neurodegenerative diseases.

Subjects

MeSH terms (MEDLINE)

Neuroprotective AgentsPhenolsAnimalsHumansNeurodegenerative DiseasesAlzheimer DiseaseDisease Models, AnimalParkinson DiseaseNeuroprotection

Author keywords

EugenolResveratrolneuroprotectionpolyphenolssecondary metabolites

Substances

Neuroprotective AgentsPhenols

Authors and institutions

  • University of Medicine of Göttingen (UMG), Göttingen, Germany.
  • HAN University of Applied Sciences, Nijmegen, The Netherlands.
  • Federal University of Ceará (UFC), Fortaleza, Brazil.

ORCID profiles: Carlos Franciney Moreira Vasconcelos, Agnieszka Zofia Neugebauer, Ricardo Basto Souza

Cite

APA

Moreira Vasconcelos, C. F., Neugebauer, A. Z., & Basto Souza, R. (2024). Exploring promising minor natural phenolic compounds in neuroprotection‐related preclinical models. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.14006

Vancouver

Moreira Vasconcelos CF, Neugebauer AZ, Basto Souza R. Exploring promising minor natural phenolic compounds in neuroprotection‐related preclinical models. Basic & Clinical Pharmacology & Toxicology. 2024. doi:10.1111/bcpt.14006

BibTeX
@article{MoreiraVasconcelos2024,
  author = {Moreira Vasconcelos, Carlos Franciney and Neugebauer, Agnieszka Zofia and Basto Souza, Ricardo},
  title = {Exploring promising minor natural phenolic compounds in neuroprotection‐related preclinical models},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2024},
  doi = {10.1111/bcpt.14006}
}
Start for free →